Kelly Posner

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. pmc Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
    Kelly Posner
    Division of Child and Adolescent Psychiatry, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 164:1035-43. 2007
  2. ncbi request reprint Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kelly Posner
    New York State Psychiatric Institute Columbia University, 1041 Riverside Drive, New York, NY 10032, USA
    J Child Adolesc Psychopharmacol 17:547-62. 2007
  3. pmc Factors in the assessment of suicidality in youth
    Kelly Posner
    Suicide Classification Center, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    CNS Spectr 12:156-62. 2007
  4. ncbi request reprint Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Howard B Abikoff
    New York University Child Study Center, 215 Lexington Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 17:581-92. 2007
  5. pmc The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up
    Mark A Riddle
    Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Baltimore, MD 21287, USA
    J Am Acad Child Adolesc Psychiatry 52:264-278.e2. 2013
  6. pmc Earlier parental set bedtimes as a protective factor against depression and suicidal ideation
    James E Gangwisch
    Columbia University, College of Physicians and Surgeons, Department of Psychiatry, New York, NY 10032, USA
    Sleep 33:97-106. 2010
  7. pmc Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health
    James E Gangwisch
    Columbia University, College of Physicians and Surgeons, Department of Psychiatry, Division of Cognitive Neuroscience, 1051 Riverside Drive, Unit 74, New York, NY 10032, USA
    Sleep 33:956-61. 2010
  8. pmc The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults
    Kelly Posner
    Department of Psychiatry, Division of Child and Adolescent Psychiatry, Columbia University, College of Physicians and Surgeons, New York, USA
    Am J Psychiatry 168:1266-77. 2011
  9. ncbi request reprint Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
    Laurence Greenhill
    Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute Columbia University, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 45:1284-93. 2006
  10. doi request reprint Attention deficit hyperactivity disorder in preschool children
    Laurence L Greenhill
    Department of Psychiatry, New York State Psychiatric Institute, Unit 78, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Child Adolesc Psychiatr Clin N Am 17:347-66, ix. 2008

Detail Information

Publications33

  1. pmc Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
    Kelly Posner
    Division of Child and Adolescent Psychiatry, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    Am J Psychiatry 164:1035-43. 2007
    ....
  2. ncbi request reprint Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kelly Posner
    New York State Psychiatric Institute Columbia University, 1041 Riverside Drive, New York, NY 10032, USA
    J Child Adolesc Psychopharmacol 17:547-62. 2007
    ..The diagnosis and evaluation process will also be described...
  3. pmc Factors in the assessment of suicidality in youth
    Kelly Posner
    Suicide Classification Center, Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    CNS Spectr 12:156-62. 2007
    ..This paper provides the clinician with a summary of risk factors for youth suicide, as well as providing standardized terminology to enhance assessment of suicidal ideation and behavior...
  4. ncbi request reprint Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Howard B Abikoff
    New York University Child Study Center, 215 Lexington Avenue, New York, NY 10016, USA
    J Child Adolesc Psychopharmacol 17:581-92. 2007
    ....
  5. pmc The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up
    Mark A Riddle
    Johns Hopkins University School of Medicine, Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, Baltimore, MD 21287, USA
    J Am Acad Child Adolesc Psychiatry 52:264-278.e2. 2013
    ..To describe the clinical course of attention-deficit/hyperactivity disorder (ADHD) symptom severity and diagnosis from ages 3 to 5 up to 9 to 12 years during a 6-year follow-up after the original Preschool ADHD Treatment Study (PATS)...
  6. pmc Earlier parental set bedtimes as a protective factor against depression and suicidal ideation
    James E Gangwisch
    Columbia University, College of Physicians and Surgeons, Department of Psychiatry, New York, NY 10032, USA
    Sleep 33:97-106. 2010
    ..Depression in an adolescent can affect his/her chosen bedtime, but it is less likely to affect a parent's chosen set bedtime which can establish a relatively stable upper limit that can directly affect sleep duration...
  7. pmc Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health
    James E Gangwisch
    Columbia University, College of Physicians and Surgeons, Department of Psychiatry, Division of Cognitive Neuroscience, 1051 Riverside Drive, Unit 74, New York, NY 10032, USA
    Sleep 33:956-61. 2010
    ..No previous published population studies have examined the longitudinal relationship between sleep duration and high cholesterol...
  8. pmc The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults
    Kelly Posner
    Department of Psychiatry, Division of Child and Adolescent Psychiatry, Columbia University, College of Physicians and Surgeons, New York, USA
    Am J Psychiatry 168:1266-77. 2011
    ..The Columbia-Suicide Severity Rating Scale (C-SSRS) was designed to quantify the severity of suicidal ideation and behavior. The authors examined the psychometric properties of the scale...
  9. ncbi request reprint Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
    Laurence Greenhill
    Division of Child and Adolescent Psychiatry, New York State Psychiatric Institute Columbia University, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 45:1284-93. 2006
    ..i.d. to children ages 3 to 5.5 years with attention-deficit/hyperactivity disorder (ADHD)...
  10. doi request reprint Attention deficit hyperactivity disorder in preschool children
    Laurence L Greenhill
    Department of Psychiatry, New York State Psychiatric Institute, Unit 78, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
    Child Adolesc Psychiatr Clin N Am 17:347-66, ix. 2008
    ..Newly available data on the safety and efficacy of pharmacotherapy and psychosocial intervention for preschoolers who have ADHD may help clinicians make treatment decisions for these young children and their families...
  11. ncbi request reprint A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD
    Laurence L Greenhill
    Attention Deficit Disorder Research Program, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:1234-41. 2003
    ..To determine the pharmacokinetic and pharmacodynamic properties of once-daily versus twice-daily doses of Adderall...
  12. pmc Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study
    Leo Sher
    Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Psychiatry Res 196:261-6. 2012
    ..Our finding has not supported the hypothesis that a response to treatment is poorer in the PTSD-MDD group which may indicate that sicker patients benefit more from the treatment...
  13. pmc Comparison of clinical and research assessments of diagnosis, suicide attempt history and suicidal ideation in major depression
    Mary E Bongiovi-Garcia
    New York State Psychiatric Institute and Columbia University 1051 Riverside Drive NY, NY 10032, United States
    J Affect Disord 115:183-8. 2009
    ....
  14. doi request reprint Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials
    Dale C Hesdorffer
    GH Sergievsky Center and Department of Epidemiology, Columbia University, New York, New York 10032, USA
    Epilepsia 54:879-87. 2013
    ..This was done to determine which instrument was optimal for use in epilepsy...
  15. pmc Effect of acute alcohol use on the lethality of suicide attempts in patients with mood disorders
    Leo Sher
    Department of Psychiatry, Division of Molecular Imaging and Neuropathology, New York State Psychiatric Institute, Columbia University, 1051 Riverside Drive, Suite 2917, Box 42, New York, NY 10032, USA
    J Psychiatr Res 43:901-5. 2009
    ..Acute alcohol use increases the lethality of suicide attempts in individuals with mood disorders...
  16. pmc Childhood onset diagnoses in a case series of teens at clinical high risk for psychosis
    Paola Mazzoni
    Center of Prevention and Evaluation, New York State Psychiatric Institute at Columbia University, New York, New York 10032, USA
    J Child Adolesc Psychopharmacol 19:771-6. 2009
    ..Little is known about disorders "usually first diagnosed in infancy, childhood and adolescence" (e.g., childhood-onset disorders) in "prodromal" teens at heightened clinical risk for psychotic disorder...
  17. doi request reprint Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence
    James E Gangwisch
    Division of Cognitive Neuroscience, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Am J Hypertens 23:62-9. 2010
    ..No previous published population studies have examined whether insomnia and sleep duration mediate the relationship between depression and hypertension incidence...
  18. ncbi request reprint Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall
    James J McGough
    Department of Psychiatry and Biobehavioral Sciences, Division of Child and Adolescent Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, USA
    J Am Acad Child Adolesc Psychiatry 42:684-91. 2003
    ..To assess the pharmacokinetic (PK) properties of a single daily dose of Adderall (mixed amphetamine salts) and the extended-release formulation, SLI381 (ADDERALL XR), in pediatric attention-deficit/hyperactivity disorder (ADHD)...
  19. ncbi request reprint Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Kristina K Hardy
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:621-34. 2007
    ....
  20. ncbi request reprint Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Desiree W Murray
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    J Child Adolesc Psychopharmacol 17:605-20. 2007
    ..To assess parent-teacher concordance on ratings of DSM-IV symptoms of attention-deficit/hyperactivity disorder (ADHD) in a sample of preschool children referred for an ADHD treatment study...
  21. ncbi request reprint Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Benedetto Vitiello
    Child and Adolescent Treatment and Preventive Intervention Research Branch, National Institute of Mental Health, 6001 Executive Boulevard, Bethesda, MD 20892, USA
    J Child Adolesc Psychopharmacol 17:593-604. 2007
    ..The aim of this study was to examine immediate-release methylphenidate effectiveness during the 10-month open-label continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Study (PATS)...
  22. ncbi request reprint A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD
    James J McGough
    University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior, 90095, USA
    J Atten Disord 9:476-85. 2006
    ..This study evaluates the efficacy, duration of action, and tolerability of methylphenidate transdermal system (MTS) in children with ADHD...
  23. ncbi request reprint Risk perception research and the black box warning for SSRIs in children
    Randall D Marshall
    J Am Acad Child Adolesc Psychiatry 45:765. 2006
  24. ncbi request reprint Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS)
    Scott Kollins
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 45:1275-83. 2006
    ..To describe the rationale and design of the Preschool ADHD Treatment Study (PATS)...
  25. ncbi request reprint Pharmacogenetics of methylphenidate response in preschoolers with ADHD
    James McGough
    UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA 90095, USA
    J Am Acad Child Adolesc Psychiatry 45:1314-22. 2006
    ..The authors explored genetic moderators of symptom reduction and side effects in methylphenidate-treated preschool-age children diagnosed with attention-deficit/hyperactivity disorder (ADHD)...
  26. ncbi request reprint Safety and tolerability of methylphenidate in preschool children with ADHD
    Tim Wigal
    University of California, Irvine, USA
    J Am Acad Child Adolesc Psychiatry 45:1294-303. 2006
    ..To report on the safety and tolerability of methylphenidate (MPH) 3- to 5-year-old children with attention-deficit/hyperactivity disorder (ADHD) during 1 year of treatment...
  27. pmc Treatment for Adolescents with Depression Study (TADS): safety results
    Graham Emslie
    UT Southwestern Medical Centre at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1440-55. 2006
    ..To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO)...
  28. ncbi request reprint Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder
    Sharon B Wigal
    Child Development Center, University of California, Irvine, California 92612, USA
    J Child Adolesc Psychopharmacol 17:153-64. 2007
    ..The aim of this study was to compare the pharmacokinetics of immediate-release methylphenidate (MPH) in preschool and school-aged children with attention-deficit/hyperactivity disorder (ADHD)...
  29. ncbi request reprint Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder
    Carroll W Hughes
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 46:667-86. 2007
    ..To revise and update consensus guidelines for medication treatment algorithms for childhood major depressive disorder based on new scientific evidence and expert clinical consensus when evidence is lacking...
  30. ncbi request reprint Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    Jaswinder K Ghuman
    University of Arizona, 1501 N Campbell Avenue, Tucson, AZ 85724, USA
    J Child Adolesc Psychopharmacol 17:563-80. 2007
    ..The aim of this study was to examine whether demographic or pretreatment clinical and social characteristics influenced the response to methylphenidate (MPH) in the Preschoolers with ADHD Treatment Study (PATS)...
  31. ncbi request reprint Stimulant-related reductions of growth rates in the PATS
    James Swanson
    Child Development Center, University of California, Irvine 92612, USA
    J Am Acad Child Adolesc Psychiatry 45:1304-13. 2006
    ..2 mg/day) administered three times daily, 7 days/week for asymptotically equal to1 year...
  32. ncbi request reprint Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)
    James M Swanson
    Child Development Center, University of California Irvine, 19722 MacArthur Boulevard, Irvine, CA 92612, USA
    J Child Adolesc Psychopharmacol 17:635-46. 2007
    ....
  33. ncbi request reprint Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD
    James T McCracken
    Department of Psychiatry and Biobehavioral Sciences, Division of Child andAdolescent Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, CA 90024 1759, USA
    J Am Acad Child Adolesc Psychiatry 42:673-83. 2003
    ..Secondary objectives included examination of the time course, pharmacokinetic, and pharmacodynamic properties of SLI381...